Functionalized CuBiS nanoparticles for dual-modal imaging and targeted photothermal/photodynamic therapy.

Nanoscale

The Key Laboratory of Resource Chemistry of Ministry of Education, Shanghai Key Laboratory of the Rare Earth Functional Materials, and Shanghai Municipal Education Committee Key Laboratory of Molecular Imaging Probes and Sensors, Shanghai Normal University, Shanghai 200234, China.

Published: March 2018

Multifunctional nano-biomaterials with the integration of diagnostic and therapeutic functions have shown great promise in improving the efficacy of cancer therapy. Herein, a new nanoplatform based on functionalized CuBiS nanoparticles (NPs) is fabricated for tumour-targeted combination phototherapy. The as-synthesized hydrophobic CuBiS NPs are modified with DSPE-PEG/DSPE-PEG-NH, followed by the conjugation of the photosensitizer chlorin e6 (Ce6) and the target ligand folic acid (FA). The introduced Ce6 can further form a chelate complex with Gd. The rationally designed CuBiS-PEG-(Ce6-Gd)-FA NPs, which have high physiological stability and good biocompatibility, can specifically target FA-receptor over-expressed tumour cells. The CuBiS-PEG-(Ce6-Gd)-FA NPs exhibit effective dual-modal CT and MR imaging in the xenografted HeLa tumours. Importantly, excellent in vivo anti-tumour effects have been achieved by synergistic photothermal/photodynamic therapy using the multifunctional NPs. We expect that this versatile nanoplatform will play a role in exploring precise cancer diagnosis and therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c7nr07458aDOI Listing

Publication Analysis

Top Keywords

functionalized cubis
8
cubis nanoparticles
8
dual-modal imaging
8
photothermal/photodynamic therapy
8
therapy multifunctional
8
cubis-peg-ce6-gd-fa nps
8
nps
5
nanoparticles dual-modal
4
imaging targeted
4
targeted photothermal/photodynamic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!